Vigil Neuroscience Statistics
Share Statistics
Vigil Neuroscience has 46.67M
shares outstanding. The number of shares has increased by 24.18%
in one year.
| Shares Outstanding | 46.67M |
| Shares Change (YoY) | 24.18% |
| Shares Change (QoQ) | 14.17% |
| Owned by Institutions (%) | 55.73% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,731 |
| FTD / Avg. Volume | 2.66% |
Short Selling Information
The latest short interest is 360.67K, so 0.77% of the outstanding
shares have been sold short.
| Short Interest | 360.67K |
| Short % of Shares Out | 0.77% |
| Short % of Float | 1.01% |
| Short Ratio (days to cover) | 4.18 |
Valuation Ratios
The PE ratio is -0.82 and the forward
PE ratio is -1.52.
Vigil Neuroscience's PEG ratio is
0.29.
| PE Ratio | -0.82 |
| Forward PE | -1.52 |
| PS Ratio | 0 |
| Forward PS | 0.3 |
| PB Ratio | 0.97 |
| P/FCF Ratio | -1.35 |
| PEG Ratio | 0.29 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Vigil Neuroscience.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95,
with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.95 |
| Quick Ratio | 2.95 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | -0.15 |
| Debt / FCF | -0.25 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,221,101.45 |
| Employee Count | 69 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -31.81% in the
last 52 weeks. The beta is 1.92, so Vigil Neuroscience's
price volatility has been higher than the market average.
| Beta | 1.92 |
| 52-Week Price Change | -31.81% |
| 50-Day Moving Average | 1.99 |
| 200-Day Moving Average | 2.71 |
| Relative Strength Index (RSI) | 56.65 |
| Average Volume (20 Days) | 177,931 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -89.68M |
| Net Income | -84.26M |
| EBITDA | -83.8M |
| EBIT | -84.26M |
| Earnings Per Share (EPS) | -2.07 |
Full Income StatementBalance Sheet
The company has 39.02M in cash and 12.95M in
debt, giving a net cash position of 26.07M.
| Cash & Cash Equivalents | 39.02M |
| Total Debt | 12.95M |
| Net Cash | 26.07M |
| Retained Earnings | -307.03M |
| Total Assets | 117.69M |
| Working Capital | 66.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -51.22M
and capital expenditures -5K, giving a free cash flow of -51.23M.
| Operating Cash Flow | -51.22M |
| Capital Expenditures | -5K |
| Free Cash Flow | -51.23M |
| FCF Per Share | -1.26 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
